European Academies Publish A Joint Report. It Says AI Helps Healthcare. They Want Oversight, Obviously.
A joint report from EASAC, the European Academies' Science Advisory Council, and FEAM, the Federation of European Academies of Medicine, examines AI across a broad range of healthcare activities. The report acknowledges major potential benefits in diagnosis, treatment, and health system efficiency. It simultaneously raises concerns about safety, ethics, data protection, and accountability.
The underlying principle is dual-use governance. Any technology powerful enough to transform diagnosis and treatment is powerful enough to cause harm at the same scale. The mechanism here is institutional risk assessment, the practice of cataloguing benefits and failure modes before deployment rather than after. The mental model to take away is that AI in medicine is not a product problem. It is a systems problem. The model is only as safe as the accountability structure surrounding it.
EASAC and FEAM, two European academy networks, jointly authored the report. It covers AI use across broad healthcare activities and specifically addresses cybersecurity, ethics, and data protection as risk categories requiring oversight.
- Open any AI chatbot and ask it to diagnose a skin rash from a description you type.
- Read the response carefully and note every place where it hedges, disclaims, or refuses to commit.
- Write down what information you would need, a doctor's examination, lab results, your medical history, to actually trust an answer. You have now replicated the core tension in the EASAC and FEAM report in about ten minutes.